Elizabeth A. Musgrove
Corresponding Author: Elizabeth A. Musgrove
The Kinghorn Cancer Centre and Cancer Research Program
Garvan Institute of Medical Research
384 Victoria Street
Australia
Name/email consistency: high
- Cyclin E2 Overexpression Is Associated with Endocrine Resistance but not Insensitivity to CDK2 Inhibition in Human Breast Cancer Cells. Caldon, C.E., Sergio, C.M., Kang, J., Muthukaruppan, A., Boersma, M.N., Stone, A., Barraclough, J., Lee, C.S., Black, M.A., Miller, L.D., Gee, J.M., Nicholson, R.I., Sutherland, R.L., Print, C.G., Musgrove, E.A. Mol. Cancer Ther. (2012)
- Biological determinants of endocrine resistance in breast cancer. Musgrove, E.A., Sutherland, R.L. Nat. Rev. Cancer (2009)
- Identification of functional networks of estrogen- and c-Myc-responsive genes and their relationship to response to tamoxifen therapy in breast cancer. Musgrove, E.A., Sergio, C.M., Loi, S., Inman, C.K., Anderson, L.R., Alles, M.C., Pinese, M., Caldon, C.E., Schütte, J., Gardiner-Garden, M., Ormandy, C.J., McArthur, G., Butt, A.J., Sutherland, R.L. PLoS. ONE (2008)
- Cyclins: roles in mitogenic signaling and oncogenic transformation. Musgrove, E.A. Growth. Factors (2006)
- Wnt signalling via the epidermal growth factor receptor: a role in breast cancer?. Musgrove, E.A. Breast Cancer Res. (2004)
- Role of the CDK inhibitor p27 (Kip1) in mammary development and carcinogenesis: insights from knockout mice. Musgrove, E.A., Davison, E.A., Ormandy, C.J. J. Mammary. Gland. Biol. Neoplasia (2004)
- Cyclin D1 overexpression induces progestin resistance in T-47D breast cancer cells despite p27(Kip1) association with cyclin E-Cdk2. Musgrove, E.A., Hunter, L.J., Lee, C.S., Swarbrick, A., Hui, R., Sutherland, R.L. J. Biol. Chem. (2001)









